KRT18 and myeloid sarcoma: Such interindividual differences may affect disease susceptibility, as is known for HERV-K18, where homozygous carriers of the K18.3 allele have a higher disease risk for MS compared with carriers of the K18.1 and K18.2 alleles [27,28].